Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms



Rating:

Share or cite this content

Citations should be made in the following way:
Linda Langehegermann (Essen, Germany), Linda Langehegermann, Ilona Spyra, Vasiliki Besa, Björn E. Kleibrink, Gerhard Weinreich, Helmut Teschler, Uwe Hillen, Bastian Schilling, Cindy Franklin, Sabine Meyer, Esra Alabas, Markus Kamler, Peter A. Horn, Vera Rebmann, Urte Sommerwerck. The influence of extracorporeal photopheresis on NFκB signaling and cytokine expression in lung transplant patients. Eur Respir J 2016; 48: Suppl. 60, 3332

Member's Comments

No comment yet.

Related content which might interest you: The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment. Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Extracorporeal photopheresis in lung transplant:The initial experience in our hospital Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Elevated levels of prostacyclin and VEGF in the rejection process after lung transplantation Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Serum cytokines patterns in lung transplant recipients Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 The effect of immunosuppression on airway integrity Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Fibrocyte involvement and increased prostacyclin and VEGF in the rejection process after lung transplantation Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004 Tacrolimus increases inflammatory cells in lung Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Peripheral CD4+CD25+ Treg cell counts and the response to extracorporeal photoapheresis in lung transplant recipients Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006